Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Ausbruch – startet jetzt die massive FDA-Rallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
86 Leser
Artikel bewerten:
(0)

Global Minimally Invasive Surgical Instruments Market 2015-2019: Medtronic, Smith & Nephew, Aesculap, Ethicon & Stryker Dominates the $14 Billion Industry

DUBLIN, Feb. 24, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/7kbzbb/minimally) has announced the addition of the "Minimally Invasive Surgical Instruments Market by Product, Application - Global Forecast to 2019" report to their offering.

600769


The minimally invasive surgical instruments market is expected to grow at a CAGR of 6.1% to reach $14,133.0 million by 2019 from $10,526.2 million in 2014

Factors such as advantages of minimally invasive surgeries over traditional open surgeries, reduced healthcare costs owing to minimally invasive surgeries, and increasing number of surgical procedures among the geriatric population are driving the global MIS instruments market. Conversely, reimbursement challenges in the medical device industry and uncertainties in regulatory policies in different regions are hindering the growth of the market.

The minimally invasive surgical instruments market is segmented on the basis of products, applications, and regions. On the basis of applications, the market is segregated into cardiothoracic surgery, vascular surgery, cosmetic/bariatric surgery, gastrointestinal surgery, gynecological surgery, urological surgery, orthopedic surgery, and others (ENT/respiratory surgery, neurological surgery, dental surgery, and pediatric surgery). Orthopedic surgery and cosmetic/bariatric surgery are expected to be the fastest-growing markets in the forecast period. Growth of these markets in attributed to the increasing prevalence of bone ailments such as osteoporosis, arthritis, and spine injuries among the elderly population and rising awareness about health concerns.

On the basis of products, the market is segmented into handheld instruments, cutter instruments, inflation systems, guiding devices, and auxiliary instruments. The handheld instruments segment is further categorized into forceps, spatulas, retractors, dilators, graspers, stents, and others (suctions and needle holders). The guiding devices segment is bifurcated into guiding catheters and guidewires. The inflation segment is categorized into balloons, balloon inflation devices, and others (insufflators and insufflator needles). The cutter instruments segment is further divided into rasps, trocars, and others (scissors, dissectors, and blades). Guiding devices are expected to be the fastest-growing segment of the minimally invasive surgical instruments products market by 2019 owing to the usage of guiding catheters and guidewires in interventional angioplasty procedures as well as in peripheral MIS procedures.

Major players operating in the global market are Medtronic plc (U.S.), Smith & Nephew plc (U.K.), Aesculap, Inc. (Germany), Ethicon, Inc. (U.S.), and Stryker Corporation (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology



3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 MIS Instruments Market, By Product

8 MIS Instruments Market, By Application

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles

- Abbott Laboratories, Inc.
- Aesculap, Inc.
- Applied Medicals
- Conmed Corporation
- Ethicon Inc. (Subsidiary of Johnson & Johnson)
- Medtronic PLC
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Holdings, Inc.

For more information visit http://www.researchandmarkets.com/research/7kbzbb/minimally

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.